Tedor Pharma, Inc.
Tedor Pharma Services is a reliable, US-based contract development and manufacturing organization (CDMO) with over 20 years of experience specializing in solid dosage forms. Headquartered in Cumberland, RI, the company offers guidance and flexible, end-to-end outsourcing solutions for small molecule drug products, including formulation development, analytical services, clinical trial services, and commercial manufacturing. Tedor emphasizes customer success, quality, and regulatory compliance, serving clients from Phase II clinical trials to commercialization, with capabilities in advanced OSD manufacturing, including HPAPIs and modified release products.
Industries
Nr. of Employees
small (1-50)
Tedor Pharma, Inc.
Products
Solid Dose Commercial Manufacturing
Full product lifecycle solid-dose manufacturing partner services from development to clinical and commercial scales, including tablets, capsules, and packaging.
Formulation & Process Development Services
Comprehensive formulation and process development services for challenging drug products, addressing complex delivery profiles, API combinations, and solubility challenges from early clinical phases to commercial scale.
Clinical Trial Supply Services
Comprehensive clinical trial supply services including investigational drug product manufacturing, formulation development, clinical packaging, labeling, logistics, and project management.
Analytical Services
Comprehensive portfolio of analytical method development, optimization solutions, and testing services supporting product development, process optimization, regulatory filing support, and quality assurance from developmental to clinical to commercial production.
Solid Dose Commercial Manufacturing
Full product lifecycle solid-dose manufacturing partner services from development to clinical and commercial scales, including tablets, capsules, and packaging.
Formulation & Process Development Services
Comprehensive formulation and process development services for challenging drug products, addressing complex delivery profiles, API combinations, and solubility challenges from early clinical phases to commercial scale.
Clinical Trial Supply Services
Comprehensive clinical trial supply services including investigational drug product manufacturing, formulation development, clinical packaging, labeling, logistics, and project management.
Analytical Services
Comprehensive portfolio of analytical method development, optimization solutions, and testing services supporting product development, process optimization, regulatory filing support, and quality assurance from developmental to clinical to commercial production.
Services
Design and optimization of immediate- and modified-release oral solid dosage formulations, including coating strategies and characterization of physicochemical properties.
GMP laboratory testing, analytical method development, characterization, and stability studies to support regulatory submissions and product release.
Manufacture of clinical trial dosage forms and placebos, clinical supply management, and associated quality assurance for clinical programs.
GMP commercial manufacturing of oral solid dose products, including scale-up, tech transfer, and production from small to large volumes.
Process optimization, validation, and technology transfer of analytical and manufacturing methods to enable commercial production.
Manufacturing and regulatory support for controlled-substance projects, including compliance with DEA licensing and quota/documentation management for Schedules II–V.
Design and optimization of immediate- and modified-release oral solid dosage formulations, including coating strategies and characterization of physicochemical properties.
GMP laboratory testing, analytical method development, characterization, and stability studies to support regulatory submissions and product release.
Manufacture of clinical trial dosage forms and placebos, clinical supply management, and associated quality assurance for clinical programs.
GMP commercial manufacturing of oral solid dose products, including scale-up, tech transfer, and production from small to large volumes.
Process optimization, validation, and technology transfer of analytical and manufacturing methods to enable commercial production.
Manufacturing and regulatory support for controlled-substance projects, including compliance with DEA licensing and quota/documentation management for Schedules II–V.
Expertise Areas
- Oral solid dosage (OSD) formulation and manufacturing
- Modified-release (MR/ER/SR/CR/DR) formulation development
- HPAPI manufacturing and containment
- Analytical method development and stability testing
Key Technologies
- Wet granulation
- Dry granulation
- Tablet compression
- Particle coating (pan and fluid-bed)
News & Updates
Event in New York City from March 17-20, 2025.
Event at Mass Bio on February 6, 2025, in Cambridge, MA.
An article discussing how virtual pharma companies can maximize outsourcing benefits.
Event in New York City from March 17-20, 2025.
Event at Mass Bio on February 6, 2025, in Cambridge, MA.
An article discussing how virtual pharma companies can maximize outsourcing benefits.